We’d like to thank everyone who joined us in attending the recent Labroots webinar, “Pathway to Implement Congenital CMV Screening and Future Legislation – One State's Progress” presented by Dr. Eileen Raynor. We appreciate you being a part of the #hearthedifference movement, committed to raising #CMVAwareness and providing fast, reliable congenital cytomegalovirus (cCMV) testing to help ensure healthier outcomes. Miss the live presentation? Watch the full webinar now to learn more about cCMV diagnostics and legislation: https://hubs.li/Q02DM8n20 Learn more about the Simplexa® Congenital CMV Direct kit, able to detect cCMV in babies under 21 days of age via saliva screening and urine confirmation: https://hubs.li/Q02DM8pX0 #hearthedifference #Awarenessmonth #cCMVAwareness
Chi siamo
DiaSorin is an Italian multinational group, one of the leading hi-tech players in the in vitro diagnostics market and, in particular, in the immunodiagnostics and molecular diagnostics segments, with over 50 years of experience. Our Group, owned by DiaSorin S.p.A., consists of 24 Companies, 5 foreign branches, offices on the 5 Continents and 6 manufacturing facilities located in Italy, Germany, UK, USA and South Africa. We are present in more than 60 countries with our direct sales network, supported by an international network of over 100 independent distributors. We develop, manufacture and market a vast and innovative line of tests for the diagnosis of infectious diseases or hormonal disorders, specifically designed for hospital and private testing laboratories, with an offer embracing different clinical areas. With more than 2000 employees all over the world, and over 210 researchers, we focus our business on improving the health and quality of people’s lives, through high-quality diagnostic products. We count on everyone’s uniqueness, with their skill and talent sets, and it’s considered a fundamental element for the creation of a working environment of excellence, able to adapt to the needs of a constantly evolving market.
- Sito Web
-
http://www.diasorin.com/
Link esterno per DiaSorin
- Settore
- Ricerca biotecnologica
- Dimensioni dell’azienda
- 1001 - 5000 dipendenti
- Sede principale
- Saluggia, VC
- Tipo
- Società privata non quotata
- Settori di competenza
- Healthcare, Biotechnology, In Vitro Diagnostic, Immunoassay, Molecular Diagnostic, Blood tests, GI Stool Testing, Vitamin D, Prenatal screening, Infectious Diseases e Life Science
Località
-
Principale
Via Crescentino
Saluggia, VC 13040, IT
-
11331 Valley View St
Cypress, California, California 90630-4717, US
-
1951 Northwestern Avenue PO BOX 285
Stillwater, Minnesota 55082 - 0285, US
-
12212 Technology Blvd
Austin, Texas 78727, US
Dipendenti presso DiaSorin
-
Riccardo Fava
Corporate VP @ Diasorin | Corporate Communications, ESG & Investor Relations
-
Jesse Nergard
Innovator in Global Talent Acquisition: Pioneering the Future of the Biotech Workforce 🌌
-
Michael Howachyn
-
Rodrigo Pellicciari
Global Sales & Commercial Operations Executive
Aggiornamenti
-
Attending ADLM 2024 in Chicago next month? Make a plan to stop by booth 1424 to discover how Diasorin and Luminex can support your diagnostic and multiplexing needs. We will have experts on hand to show how our trusted testing solutions can help you accelerate your diagnostic stewardship initiatives, multiple educational presentations in our booth, and see how you can achieve a competitive edge with our xMAP® Multiplexing Technology. See you in Chicago, July 30th – August 1st! Still need to register? https://hubs.li/Q02DMbJt0 #ADLM2024 #Immunodiagnostics #MolecularDiagnostics #xMAP
-
Diasorin is proud to create awareness of CMV along with the National CMV Foundation who are at the forefront of CMV education. Did you know that congenital CMV (cCMV) is the most common infectious cause of birth defects in the US and that one out of five babies with congenital CMV will develop long-term health problems, such as hearing loss? Diasorin has assays that can support a physician’s diagnosis in two ways: The mother: The LIAISON® CMV assay panel (IgG, IgM) is a complete solution to aid clinicians in patient assessment of CMV. The diagnosis of Human Cytomegalovirus infection in pregnant women is of particular importance in assessing risk of fetal damage. The baby: Diasorin’s Simplexa® Congenital CMV Direct assay is the only FDA-cleared PCR assay for the detection of CMV in both saliva swabs and urine. PCR testing in the first 3 weeks of life can aid in determining if an infant has congenital CMV. An early diagnosis allows for prompt treatment of hearing loss and provides an opportunity for early intervention for better health outcomes. Join the movement #hearthedifference with Diasorin as we do our part to ensure that babies get a chance to live healthy and happy lives and visit our website to learn more: https://hubs.li/Q02CV8bV0 https://hubs.li/Q02CV2t30 #Diasorin #Diagnostictesting #congenitalCMV #CMV
-
Are you interested in learning about paving a pathway to implement congenital cytomegalovirus (cCMV) screening in your state? Join us on @Labroots on June 25th at 12:00 p.m. EDT to hear Dr. Eileen Raynor discuss #cCMV screening and efforts for legislation in North Carolina in the upcoming webinar, "Pathway to Implement Congenital CMV Screening and Future Legislation – One State's Progress”. Register now: https://hubs.ly/Q02CyJ-70 See how the Simplexa® Congenital CMV Direct kit can help you detect cCMV in babies under 21 days of age with 2 cleared sample types: saliva swab for screening and urine for confirming. https://hubs.ly/Q02CytC10 #hearthedifference #Awarenessmonth #cCMVAwareness
-
Thank you for another great year at #ASMMicrobe2024! It was truly a privilege to connect with so many colleagues and friends over the latest innovations in diagnostic healthcare. We hope you enjoyed experiencing the LIAISON PLEX® System and the LIAISON PLEX® Respiratory Flex Assay in person and learning how your lab can benefit from our first fully customizable diagnostic testing solution. Didn’t have the chance to stop by our booth? Not a worry! Visit our website to learn more about our newest products: https://hubs.li/Q02B-tZq0 We look forward to seeing you next year in Los Angeles, CA! #LIAISONPLEX #moleculartesting #healthcare #ASMicrobe
-
Be sure to come see our two posters today—featuring Diasorin Products—at the CPHM section in the back right quadrant of #ASMMIcrobe2024 exhibit hall. Look for the orange "CPHM Track Hub" sign. #CPHM-SUNDAY-271 Progress Towards Developing a Highly Multiplexed Fungal Bloodstream Infection Diagnostic #CPHM-SUNDAY-224 The Development of a Highly Multiplexed Sample-to-Answer Gram Positive Blood Culture Pathogen Diagnostic for Sepsis Be sure to stop by booth #925 afterwards to see the brand-new LIAISON PLEX® System and LIAISON PLEX® Respiratory Flex Assay in person before the exhibits close. We look forward to speaking with you soon! Learn more about LIAISON PLEX®: https://hubs.li/Q02B-t7X0 #LIAISONPLEX #moleculartesting #healthcare #ASMicrobe
-
We’re set up and ready to go at #ASMMicrobe2024! Come visit us at booth #925 for a first look at our new sample-to-customizable answer LIAISON PLEX® System, LIAISON PLEX® Respiratory Flex Assay, and more! Learn more about LIAISON PLEX: https://hubs.li/Q02BShWM0 #LIAISONPLEX #moleculartesting #healthcare #ASMicrobe
-
Today, on World Blood Donor Day, we at Diasorin stand alongside World Health Organization and communities worldwide to celebrate 20 years of giving. Thank you, blood donors, for your life-saving contributions! Let's continue to work together to ensure safe blood transfusion for all. #Diasorin #WorldBloodDonorDay #BloodDonation
-
How much do you know about Diasorin’s next-generation, sample-to-answer syndromic molecular platform, the LIAISON PLEX®? Please join us ftomorrow for our workshop, “Diagnostic Stewardship and Customizable Syndromic Molecular Testing with LIAISON PLEX®,” where we will be featuring a presentation by James W. Snyder, PhD, D(ABMM), F(AAM), Professor, Department of Pathology and Laboratory Medicine, University of Louisville School of Medicine, "Diagnostic Stewardship in the Clinical Microbiology Laboratory," and by Coreen Johnson, PhD, MT (ASCP) from the Texas Children's Hospital-Department of Pathology, “LIAISON PLEX® Respiratory Flex Evaluation in a Pediatric Population,” June 14th from 12:00 p.m. to 12:45 p.m., Theater A in the Exhibit Hall. We hope to see you there! Learn more about LIAISON PLEX - https://hubs.li/Q02zzd880 #ASMMicrobe2024 #LIAISONPLEX #Biotech
-
The Simplexa® Congenital CMV Direct kit is the first FDA-cleared PCR assay for the detection and confirmation of congenital CMV in both saliva and urine, providing results you can trust in under 60 minutes. Visit Diasorin at ASM Microbe 2024, booth number 925 to learn more about the Simplexa® Congenital CMV Direct kit, the LIAISON PLEX® Respiratory Flex Assay, and more! Discover the Simplexa® Congenital CMV Direct kit: https://hubs.li/Q02zzr0r0 #ASMMicrobe2024 #Simplexa #Biotech #cCMV